Clinical trial
Randomized Phase 3 Trial Evaluating the Efficacy of Locoregional Treatment With Transarterial Embolization (TAE) for Liver Metastases, in Combination With Pharmacotherapy, in Patients With Neuroendocrine Tumor and Inoperable Liver Metastasis.
NCT01755182 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase 3 Trial Evaluating the Efficacy of Locoregional Treatment With Transarterial Embolization (TAE) for Liver Metastases, in Combination With Pharmacotherapy, in Patients With Neuroendocrine Tumor and Inoperable Liver Metastasis.
- Lead sponsor
- National Cancer Institute, Naples
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- July 31, 2013
- Completion date
- March 31, 2016
- Enrollment
- 1 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.